1. Home
  2. FOA vs MSLE Comparison

FOA vs MSLE Comparison

Compare FOA & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finance of America Companies Inc.

FOA

Finance of America Companies Inc.

HOLD

Current Price

$24.12

Market Cap

177.1M

Sector

Finance

ML Signal

HOLD

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$6.85

Market Cap

146.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FOA
MSLE
Founded
2013
N/A
Country
United States
Canada
Employees
784
17
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
146.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FOA
MSLE
Price
$24.12
$6.85
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$26.00
N/A
AVG Volume (30 Days)
41.0K
31.4K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.58
N/A
Revenue Next Year
$6.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.77
$5.44
52 Week High
$29.58
$13.39

Technical Indicators

Market Signals
Indicator
FOA
MSLE
Relative Strength Index (RSI) 77.59 58.62
Support Level $21.69 $6.71
Resistance Level $25.50 $8.59
Average True Range (ATR) 1.18 0.34
MACD 0.39 0.13
Stochastic Oscillator 88.77 87.36

Price Performance

Historical Comparison
FOA
MSLE

About FOA Finance of America Companies Inc.

Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: